Related Experiment Videos
[Dementia in progressive supranuclear paralysis patients].
M S Barquero-Jiménez1, M Domínguez-Salgado
1Servicio de Neurología; Hospital Clínico Universitario San Carlos, Madrid, 28040, España. mbarquero@hcsc.insalud.es
Revista De Neurologia
|September 20, 2001
Summary
Diagnosing progressive supranuclear palsy (PSP) early is challenging due to non-specific symptoms often mistaken for Parkinson's or Alzheimer's disease. This study details PSP's clinical features and progression, aiding earlier identification.
Area of Science:
- Neurology
- Neuroscience
- Clinical Medicine
Context:
- Progressive supranuclear palsy (PSP) presents diagnostic challenges in early stages.
- Symptoms overlap with Parkinson's disease and Alzheimer's disease, leading to misdiagnosis.
Purpose:
- To describe the clinical data and evolutionary profile of progressive supranuclear palsy.
- To highlight key features that can aid in distinguishing PSP from other neurodegenerative conditions.
Summary:
- Early PSP signs include gait disturbance, falls, behavioral changes, and dysarthria.
- Characteristic gaze palsy may appear late; motor signs include rigidity and bradykinesia.
- Cognitive deficits typical of subcortical dementia are present, with notable visuospatial impairment.
Impact:
- Improved early detection and diagnosis of progressive supranuclear palsy.
- Enhanced understanding of PSP's clinical presentation and cognitive profile.
- Potential to differentiate PSP from other dementias, optimizing patient management.